The WW Domain of Dystrophin Requires EF-Hands Region to Interact with β-Dystroglycan

Abstract Skeletal muscle dystrophin is a 427 kDa protein thought to act as a link between the actin cytoskeleton and the extracellular matrix. Perturbations of the dystrophin-associated complex, for example, between dystrophin and the transmembrane glycoprotein β-dystroglycan, may lead to muscular dystrophy. Previously, the cysteine-rich region and first half of the carboxy-terminal domain of dystrophin were shown to interact with β-dystroglycan through a stretch of fifteen amino acids at the carboxy-terminus of β-dystroglycan. This region of dystrophin implicated in binding β-dystroglycan contains four modular protein domains: a WW domain, two putative Ca2+-binding EF-hand motifs, and a putative zinc finger ZZ domain. The WW domain is a globular domain of 38–40 amino acids with two highly conserved tryptophan residues spaced 20–22 amino acids apart. A subset of WW domains was shown to bind ligands that contain a Pro-Pro-x-Tyr core motif (where x is any amino acid). Here we elucidate the role of the WW domain of dystrophin and surrounding sequence in binding β-dystroglycan. We show that the WW domain of dystrophin along with the EF-hand motifs binds to the carboxy-terminus of β-dystroglycan. Through site-specific mutagenesis and in vitro binding assays, we demonstrate that binding of dystrophin to the carboxyterminus of β-dystroglycan occurs via a β-dystroglycan Pro-Pro-x-Tyr core motif. Targeted mutagenesis of conserved WW domain residues reveals that the dystrophin/β-dystroglycan interaction occurs primarily through the WW domain of dystrophin. Precise mapping of this interaction could aid in therapeutic design.

[1]  J. Flanagan,et al.  Cloning and characterization of RTK ligands using receptor-alkaline phosphatase fusion proteins. , 2001, Methods in molecular biology.

[2]  M. Eck,et al.  STRUCTURE OF THE N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE IN ZAP-70 , 1999 .

[3]  M. Sudol,et al.  The WW Domain of Neural Protein FE65 Interacts with Proline-rich Motifs in Mena, the Mammalian Homolog of DrosophilaEnabled* , 1997, The Journal of Biological Chemistry.

[4]  Scott A. Peterson,et al.  Characterization of the WW Domain of Human Yes-associated Protein and Its Polyproline-containing Ligands* , 1997, The Journal of Biological Chemistry.

[5]  M. Saraste,et al.  Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X‐linked agammaglobulinaemia , 1997, The EMBO journal.

[6]  A. Sparks,et al.  Identification of Novel Human WW Domain-containing Proteins by Cloning of Ligand Targets* , 1997, The Journal of Biological Chemistry.

[7]  P. Leder,et al.  FBP WW domains and the Abl SH3 domain bind to a specific class of proline‐rich ligands , 1997, The EMBO journal.

[8]  J. Forman-Kay,et al.  NMR studies of unfolded states of an SH3 domain in aqueous solution and denaturing conditions. , 1997, Biochemistry.

[9]  M. Sudol.  The WW Domain and its Proline-Rich Ligand in Alzheimer's Disease and Muscular Dystrophy , 1997 .

[10]  B. G. Wallace.  Signaling mechanisms mediating synapse formation. , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[11]  M. Saraste,et al.  Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide , 1996, Nature.

[12]  C. Hübner,et al.  A cysteine 3340 substitution in the dystroglycan-binding domain of dystrophin associated with Duchenne muscular dystrophy, mental retardation and absence of the ERG b-wave. , 1996, Human molecular genetics.

[13]  K. Campbell,et al.  Forced expression of dystrophin deletion constructs reveals structure- function correlations , 1996, The Journal of cell biology.

[14]  T. Petrucci,et al.  Localization of the dystrophin binding site at the carboxyl terminus of beta-dystroglycan. , 1996, Biochemical and biophysical research communications.

[15]  M. Sudol.  The WW module competes with the SH3 domain? , 1996, Trends in biochemical sciences.

[16]  M. Sudol,et al.  Towards prediction of cognate complexes between the WW domain and proline‐rich ligands , 1996, FEBS letters.

[17]  P. Leder,et al.  Formin binding proteins bear WWP/WW domains that bind proline‐rich peptides and functionally resemble SH3 domains. , 1996, The EMBO journal.

[18]  C. Ponting,et al.  ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins. , 1996, Trends in biochemical sciences.

[19]  M. Sudol,et al.  Structure and function of the WW domain. , 1996, Progress in biophysics and molecular biology.

[20]  M. Michalak,et al.  Phosphorylation of the carboxyl-terminal region of dystrophin. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[21]  M. Ikura.  Calcium binding and conformational response in EF-hand proteins. , 1996, Trends in biochemical sciences.

[22]  K. Campbell,et al.  Identification and Characterization of the Dystrophin Anchoring Site on β-Dystroglycan (*) , 1995, The Journal of Biological Chemistry.

[23]  Eva Thulin,et al.  Calcium-induced structural changes and domain autonomy in calmodulin , 1995, Nature Structural Biology.

[24]  Ad Bax,et al.  Solution structure of calcium-free calmodulin , 1995, Nature Structural Biology.

[25]  Mitsuhiko Ikura,et al.  Calcium-induced conformational transition revealed by the solution structure of apo calmodulin , 1995, Nature Structural Biology.

[26]  M. Sudol,et al.  The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Gibson,et al.  Dystrophin and utrophin: the missing links! , 1995, FEBS letters.

[28]  A J Wand,et al.  Structural analysis of a novel interaction by calmodulin: high-affinity binding of a peptide in the absence of calcium. , 1995, Biochemistry.

[29]  K. Campbell,et al.  SH3 Domain-mediated Interaction of Dystroglycan and Grb2(*) , 1995, The Journal of Biological Chemistry.

[30]  K. Campbell,et al.  Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. , 1995, The Journal of biological chemistry.

[31]  T. Vorherr,et al.  Calmodulin-binding domains: just two faced or multi-faceted? , 1995, Trends in biochemical sciences.

[32]  M Ikura,et al.  Molecular and structural basis of target recognition by calmodulin. , 1995, Annual review of biophysics and biomolecular structure.

[33]  P. Bork,et al.  The WW domain: a signalling site in dystrophin? , 1994, Trends in biochemical sciences.

[34]  Aaron Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway , 1994, Cell.

[35]  B. Rost,et al.  Combining evolutionary information and neural networks to predict protein secondary structure , 1994, Proteins.

[36]  Kensuke Hayashi,et al.  Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. , 1994, European journal of biochemistry.

[37]  Burkhard Rost,et al.  PHD - an automatic mail server for protein secondary structure prediction , 1994, Comput. Appl. Biosci..

[38]  F A Quiocho,et al.  Modulation of calmodulin plasticity in molecular recognition on the basis of x-ray structures. , 1993, Science.

[39]  A. Kramer,et al.  Simultaneous synthesis of peptide libraries on single resin and continuous cellulose membrane supports: examples for the identification of protein, metal and DNA binding peptide mixtures. , 1993, Peptide research.

[40]  U. Francke,et al.  Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. , 1993, Human molecular genetics.

[41]  B. Rost,et al.  Prediction of protein secondary structure at better than 70% accuracy. , 1993, Journal of molecular biology.

[42]  H. Sweeney,et al.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Gronenborn,et al.  Solution structure of a calmodulin-target peptide complex by multidimensional NMR. , 1994, Science.

[44]  M. Michalak,et al.  Isolation and characterization of different C-terminal fragments of dystrophin expressed in Escherichia coli. , 1992, The Biochemical journal.

[45]  F A Quiocho,et al.  Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex. , 1992, Science.

[46]  Hideko Yamamoto,et al.  Glycoprotein‐binding site of dystrophin is confined to the cysteine‐rich domain and the first half of the carboxy‐terminal domain , 1992, FEBS letters.

[47]  C. Caskey,et al.  An intact cysteine-rich domain is required for dystrophin function. , 1992, The Journal of clinical investigation.

[48]  Peggy J. Farnham,et al.  Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties , 1992, Cell.

[49]  D. Bentley,et al.  Point mutations in the dystrophin gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[50]  O. Ibraghimov-Beskrovnaya,et al.  Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix , 1992, Nature.

[51]  L. Kunkel,et al.  Dystrophin: the protein product of the Duchene muscular dystrophy locus. 1987. , 1992, Biotechnology.

[52]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[53]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[54]  J. Ervasti,et al.  Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.

[55]  R. Frank,et al.  An Efficient Method for Anchoring FMOC-Amino Acids to Hydroxyl-Functionalized Solid Supports. , 1990 .

[56]  E. Ozawa,et al.  Glycoprotein complex anchoring dystrophin to sarcolemma. , 1990, Journal of biochemistry.

[57]  L. Kunkel,et al.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. , 1989, American journal of human genetics.

[58]  A. Monaco,et al.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein , 1988, Cell.

[59]  R. Frank,et al.  Simultaneous multiple peptide synthesis under continuous flow conditions on cellulose paper discs as segmental solid supports , 1988 .

[60]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[61]  M. Koenig,et al.  Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.

[62]  P. Ray,et al.  A cDNA clone from the Duchenne/Becker muscular dystrophy gene , 1987, Nature.

[63]  A. Monaco,et al.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene , 1986, Nature.

[64]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[65]  R. Kretsinger,et al.  Troponin and parvalbumin calcium binding regions predicted in myosin light chain and T4 lysozyme. , 1975, Science.

[66]  R. Kretsinger,et al.  Carp muscle calcium-binding protein. II. Structure determination and general description. , 1973, The Journal of biological chemistry.